These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 17612931
61. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy. Chen Y, Guo W, Lu Y, Zou B. Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684 [Abstract] [Full Text] [Related]
62. Role of adjuvant chemotherapy in NSCLC (stages I to III). Coleman MH, Bueno R. Surg Oncol Clin N Am; 2011 Oct; 20(4):757-67. PubMed ID: 21986270 [Abstract] [Full Text] [Related]
63. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM. Cancer; 2009 Sep 15; 115(18):4156-66. PubMed ID: 19551884 [Abstract] [Full Text] [Related]
64. [Current status of postoperative adjuvant chemotherapy for completely resected non-small lung cancer]. Tsuboi M. Nihon Geka Gakkai Zasshi; 2014 May 15; 115(3):125-9. PubMed ID: 24946518 [Abstract] [Full Text] [Related]
65. [Pre-operative chemotherapy in non-small cell lung cancer]. Betticher DC, Depierre A. Rev Mal Respir; 2005 Dec 15; 22(6 Pt 2):8S112-7. PubMed ID: 16340846 [Abstract] [Full Text] [Related]
66. [Lung cancer]. Tsuboi M, Kato H. Gan To Kagaku Ryoho; 2007 Oct 15; 34(10):1538-42. PubMed ID: 17940368 [Abstract] [Full Text] [Related]
67. [Early-stage NSCLC. Resectable non-small cell lung cancers: (neo) adjuvant chemotherapy]. Berghmans T. Rev Mal Respir; 2008 Oct 15; 25(8 Pt 2):3S72-8. PubMed ID: 18971829 [Abstract] [Full Text] [Related]
73. [Early stages of non small cell lung cancer (I. II. IIIA). Role of preoperative treatments]. Depierre A. Rev Mal Respir; 2006 Nov 15; 23(5 Pt 3):16S43-16S46. PubMed ID: 17268335 [Abstract] [Full Text] [Related]
74. Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. Kassam F, Shepherd FA, Johnston M, Visbal A, Feld R, Darling G, Keshavjee S, Pierre A, Waddell T, Leighl NB. J Thorac Oncol; 2007 Jan 15; 2(1):39-43. PubMed ID: 17410008 [Abstract] [Full Text] [Related]
77. [Adjuvant treatments of non-small cell lung cancer]. Moretti L, Roelandts M, Berghmans T, Van Houtte P. Cancer Radiother; 2007 Jan 15; 11(1-2):53-8. PubMed ID: 16843029 [Abstract] [Full Text] [Related]
79. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer? Radosavljevic D, Golubicic I, Gavrilovic D, Kezic I, Jelic S. J BUON; 2009 Jan 15; 14(2):203-9. PubMed ID: 19650167 [Abstract] [Full Text] [Related]
80. [The role of adjuvant chemotherapy in the treatment of non-small cell lung cancer]. Szondy K, Egri G. Magy Onkol; 2006 Jan 15; 50(3):229-32. PubMed ID: 17099782 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]